Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Why Viking Therapeutics Stock Is Heating Up Today

TheMotleyFool 
0 0 31.05.23
Why Viking Therapeutics Stock Is Heating Up Today: https://g.foolcdn.com/editorial/images/734583/growth-chart.jpg
 

Shares of the metabolic disease specialist Viking Therapeutics (NASDAQ: VKTX) were up by 6.6% on slightly below-average volume as of 1:56 p.m. ET Wednesday afternoon. The biotech's stock is heating up in response to a positive take by the private investment bank Roth Capital Partners.

The firm initiated coverage today on Viking's stock, rolling out a $32 per-share price target on the biotech in the process. This notable 12-month price target implies a hefty upside potential of 55% relative to Tuesday's close. 

Roth's stately price target isn't the only reason investors are piling into the biotech today. The firm also stated that its lead product candidates in obesity (VK2735) and nonalcoholic steatohepatitis (NASH) (VK2809) sport favorable clinical profiles that bode well for their long-term success.

Continue reading


Source Fool.com

Viking Therapeutics Inc Stock

€48.54
-1.680%
A loss of -1.680% shows a downward development for Viking Therapeutics Inc.

Show more
Like: 0
VKTX
Share

Comments

Not a member yet? Sign up for free!